Risk of medication-induced lactic acidosis and hyperlactatemia: a pharmacovigilance study of the United States Food and Drug Administration’s Adverse Event Reporting System database
ObjectiveLactic acidosis and hyperlactatemia (LAHL) are predictors of poor clinical outcomes in critically ill patients. This research aimed to specify medications reported in association with LAHL, thus providing valuable insights into medication safety.MethodsSpontaneous reports were excavated fro...
Saved in:
| Main Authors: | Houci Yang, Haibin Dai, Xveying Chen, Jiaqi Huang, Fangzhou Miao, Jiani Lv, Jiali Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1555955/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
by: Runan Fang, et al.
Published: (2024-11-01) -
Lactic acidosis in the practice of a resuscitator
by: V. V. Skvortsov, et al.
Published: (2020-06-01) -
Venlafaxine intoxication in an adolescent presenting with severe lactic acidosis
by: İrem Eldem, et al.
Published: (2016-04-01) -
Pharmacovigilance of lower urinary tract adverse events among commonly prescribed medications: A FAERS database analysis
by: Robert Adler, et al.
Published: (2025-06-01) -
Metformin-Associated Lactic Acidosis (MALA). Our experiencie and a review
by: Enrique Chicote-Álvarez, et al.
Published: (2025-01-01)